Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain
about
Contemporary murine models in preclinical astrocytoma drug developmentA mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levelsInhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathwaysRedox biology and the interface between bioenergetics, autophagy and circadian control of metabolismMetabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production.Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cellsTherapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme.Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.A novel class of mitochondria-targeted soft electrophiles modifies mitochondrial proteins and inhibits mitochondrial metabolism in breast cancer cells through redox mechanisms.Differential regulation of metabolism by nitric oxide and S-nitrosothiols in endothelial cells.Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomasCancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodelingO6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Expression and clinical significance of cytochrome c oxidase subunit IV in colorectal cancer patients.Mitochondrial oncobioenergetic index: A potential biomarker to predict progression from indolent to aggressive prostate cancer.Integration of cellular bioenergetics with mitochondrial quality control and autophagy.The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition.Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide.Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.Metabolic reprogramming of the tumor.Current evidence of temozolomide and bevacizumab in treatment of gliomas.Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature.Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells.Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress.Dysfunctional mitochondrial bioenergetics and oxidative stress in Akita(+/Ins2)-derived β-cellsHyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide.Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase.Downregulation of cytochrome c oxidase 1 induced radioresistance in esophageal squamous cell carcinoma
P2860
Q27026937-C47616D1-84DD-458D-84D5-B60D6EAC13E1Q28238894-6B6E19D2-71DF-490B-8217-330A64A8A525Q28286344-E0A751FC-FA40-4CC7-9BC4-3D52C198A47CQ28394996-59374B1A-AB89-46C2-8E66-DF1165D8066BQ33829265-BAB1E837-FA64-4259-9B16-3AC8CDD66DB3Q33911224-0D7D8B32-B936-44B1-B165-59E3E5292A61Q33914038-0FEB4FEC-487A-4AF5-A442-4E578BE2CC2AQ33992432-3BE54216-055F-40AF-A6B5-75A844179CB4Q34023873-568827BF-CBF8-46BF-9388-05A639D06101Q34042498-CD642170-2543-45EC-8299-F32351012ADAQ34321143-5C1A7EEE-69EC-453B-8C5A-FB5DDB8B26D2Q34417525-C7A8A4AB-9808-4427-A3E2-D880544F34B4Q34674502-270917CC-2040-40B5-88B8-D0493AFCB082Q35038005-64136D9E-8960-4716-9DEC-EB498DAD6E16Q35191770-862CEF26-9789-401E-83DB-BEC9E254E5F3Q35315038-8769C7A4-0CE2-421F-BD54-C7993E942E3EQ35552014-7BB7AD49-0CF0-4996-9B71-9B0B3007C842Q36228895-18221210-4060-4B59-9481-0EC5C8FAC9F2Q36288503-25ED148D-773F-4C14-925D-76D77C7FE8C6Q36561571-B74AA5BC-A810-4757-8185-D2132A5B3B3AQ36582356-5BD17ABF-E8E1-4703-B4D8-B1248097DEF1Q36619120-266377A6-D063-4E14-9CCB-61B491429258Q36675381-DDBFCF92-2EEE-40FC-B36B-A8A21B6741DCQ36779495-1892D367-B5BD-404F-A8AF-82B0D5B9B099Q36875981-E8C89F1F-24D4-4D45-B468-B28826BFD013Q36981674-3E59F1D0-4263-46B0-B150-623357C1BE54Q37061545-A360951F-C4C8-4212-8D94-8AD2AA08DA08Q37187689-5FD6D13C-670F-44FF-BA9C-F99C06E02BA8Q37475020-5807D047-FF7A-4255-8BA1-A49A5373E45EQ37974518-E9DC530E-15E3-4219-B653-BE20E18BB452Q38230650-F9874E3F-3364-45A2-A8EC-170314DC2BECQ38400485-53F2C84D-D045-43C1-9F1B-C42FAA41BB1BQ38557882-95250CA9-365C-49C7-8ED9-A29E61717894Q38689955-543B9624-3B8E-405E-99B1-123CAC635A0FQ38743394-E54435DB-324F-41A6-A44E-7F871BCAE9B6Q38951473-EA85F092-9189-4390-A26C-65F26BC5A0F1Q39131463-9424FD6C-58F0-467A-A8F9-04108BB1BAF3Q39319634-481BB28A-28B3-4C71-9682-1133086B459EQ41453815-CE724477-E8BC-4431-8CA0-A8CA49A48533Q41701871-F5FB7F1A-7D5A-4253-8681-52F2211EE4A4
P2860
Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Acquisition of temozolomide ch ...... drial electron transport chain
@ast
Acquisition of temozolomide ch ...... drial electron transport chain
@en
Acquisition of temozolomide ch ...... drial electron transport chain
@nl
type
label
Acquisition of temozolomide ch ...... drial electron transport chain
@ast
Acquisition of temozolomide ch ...... drial electron transport chain
@en
Acquisition of temozolomide ch ...... drial electron transport chain
@nl
prefLabel
Acquisition of temozolomide ch ...... drial electron transport chain
@ast
Acquisition of temozolomide ch ...... drial electron transport chain
@en
Acquisition of temozolomide ch ...... drial electron transport chain
@nl
P2093
P2860
P356
P1476
Acquisition of temozolomide ch ...... drial electron transport chain
@en
P2093
Aimee Landar
Anne Diers
Claudia R Oliva
Corinne E Griguer
G Yancey Gillespie
James M Markert
Jann N Sarkaria
Samuel G McClugage
Shannon M Bailey
Susan E Nozell
P2860
P304
39759-39767
P356
10.1074/JBC.M110.147504
P407
P577
2010-09-24T00:00:00Z